Kimen Colgan
Physician Assistant · Arroyo Grande, CANPI 1699739227
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,399 and has fallen 80.1% since, to $477 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$729
- Johnson & Johnson$310
- Biohaven Pharmaceuticals, Inc.$289
- Novo Nordisk$284
- Merck$261
- Eisai Inc.$239
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,81296%
- Education$1634%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $729 |
| Johnson & Johnson(2 entities) | 21 | $310 |
| Biohaven Pharmaceuticals, Inc. | 14 | $289 |
| Novo Nordisk | 36 | $284 |
| Merck | 14 | $261 |
| Eisai Inc. | 13 | $239 |
| GSK | 21 | $190 |
| AstraZeneca | 8 | $179 |
| Sunovion Pharmaceuticals Inc. | 10 | $141 |
| Astellas Pharma US Inc | 5 | $129 |
| Lilly USA, LLC | 8 | $114 |
| Seagen Inc. | 5 | $102 |
| Pfizer | 5 | $99 |
| Amgen | 3 | $92 |
| Boehringer Ingelheim | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| UCB, Inc. | 2 | $58 |
| Mylan Specialty L.p. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Exelixis Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $36 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Mirati Therapeutics, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Bayer | 1 | $27 |
| Radius Health, Inc. | 1 | $26 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Sobi, Inc | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Secura Bio, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $14 |
How this compares
$3,975 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 29 | $516,078 |
| TasignaNilotinib Hcl | 14 | $140,686 |
| Letrozole | 28 | $1,525 |
| Tamoxifen Citrate | 54 | $1,163 |
| Oxycodone Hcl | 38 | $574 |
| Ondansetron Hcl | 28 | $345 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $333 |
| Anastrozole | 19 | $275 |
| Dexamethasone | 26 | $254 |
| Sertraline Hcl | 15 | $214 |
| Levothyroxine Sodium | 28 | $206 |
| Omeprazole | 26 | $175 |
| Pantoprazole Sodium | 16 | $158 |
| Trazodone Hcl | 20 | $144 |
| Warfarin Sodium | 13 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationJakafi | $14 | $516,07829 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $21415 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $20628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Arroyo Grande
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Asma HussainiThousand Oaks$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.